Valuation Genscript Biotech Corporation

Stocks

Market Closed - Hong Kong S.E. Other stock markets 09:08:36 10/07/2026 BST			5-day change	1st Jan Change
13.84 ^HKD	+4.85%		+1.69%	+11.43%

06-15	Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma	MT
06-14	Genscript Biotech Corporation Reports 100% Response Rate in Early Trial of LB2501 Dual-Targeting CAR-T Therapy for Relapsed B-Cell Lymphoma	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	9,297	6,741	5,398	2,716	3,489	3,863	-	-
Change	-	-27.49%	-19.93%	-49.68%	28.45%	10.73%	-	-
Enterprise Value (EV) ¹	8,053	5,838	3,992	2,408	3,340	3,822	3,761	3,582
Change	-	-27.5%	-31.62%	-39.69%	38.72%	14.42%	-1.59%	-4.75%
P/E	-25.8x	-29.5x	-56.1x	0.93x	-6.49x	44.4x	18.8x	12.5x
PBR	10.5x	6.66x	3.88x	0.62x	0.87x	0.94x	0.89x	0.79x
PEG	-	0.8x	1x	-0x	0x	-0x	0x	0.2x
Capitalization / Revenue	18.2x	10.8x	6.43x	4.57x	3.64x	4.74x	4.15x	3.7x
EV / Revenue	15.8x	9.33x	4.76x	4.05x	3.48x	4.68x	4.04x	3.43x
EV / EBITDA	-25.4x	-15.7x	-11.8x	31.1x	10.2x	30.7x	18.8x	13.8x
EV / EBIT	-22.4x	-13.4x	-9.71x	152x	13.2x	57x	43.1x	33.3x
EV / FCF	-29.4x	-17.2x	13x	-19.8x	13.8x	30.1x	28.1x	15x
FCF Yield	-3.41%	-5.8%	7.69%	-5.04%	7.24%	3.32%	3.56%	6.67%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.1713	-0.1082	-0.0453	1.36	-0.2458	0.0398	0.0938	0.1415
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	511.1	625.7	839.5	594.5	959.5	815.8	931.1	1,045
EBITDA ¹	-317.3	-372.6	-337.1	77.38	328	124.5	200.5	259.4
EBIT ¹	-359.7	-436.8	-411	15.84	253.9	67	87.35	107.5
Net income ¹	-347.9	-226.9	-95.48	2,962	-532.8	74.8	218.8	360.1
Net Debt ¹	-1,245	-902.7	-1,405	-308.2	-148.7	-41.61	-102.3	-281
Reference price ²	4.424	3.187	2.542	1.267	1.596	1.765	1.765	1.765
Nbr of stocks (in thousands)	2,101,341	2,115,207	2,123,163	2,143,970	2,186,379	2,188,417	-	-
Announcement Date	20/03/22	30/03/23	10/03/24	12/03/25	15/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENSCRIPT BIOTECH CORPORATION	44.41x	4.68x	30.7x	-.--%	3.86B
LONZA GROUP AG	35.38x	6.18x	19.12x	0.93%	50.73B
REVOLUTION MEDICINES, INC.	-23.4x	342.07x	-22.1x	-.--%	39.73B
IQVIA HOLDINGS INC.	25.29x	2.8x	12.09x	-.--%	34.69B
BEONE MEDICINES AG	45.73x	4.51x	28.9x	-.--%	33.21B
CELLTRION, INC.	27.05x	7.93x	19.91x	0.42%	26.76B
MEDPACE HOLDINGS, INC.	31.75x	5.12x	23.32x	-.--%	15.37B
EUROFINS SCIENTIFIC SE	23.95x	2.04x	8.96x	1.12%	13.78B
ICON PUBLIC LIMITED COMPANY	23.74x	1.89x	11.45x	-.--%	12.85B
Average	25.99x	41.91x	14.71x	0.27%	25.66B
Weighted average by Cap.	22.86x	62.83x	11.91x	0.32%